FIELD: medicine.
SUBSTANCE: method involves determining endothelin-1 concentration in blood plasma. Its value being equal to 1.5-5 fmole/ml, treatment with Nebivolol is administered.
EFFECT: enhanced effectiveness in selecting patients for applying treatment with Nebivolol.
1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RISK OF PROGRESSING CHRONIC HEART FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2019 |
|
RU2734671C1 |
| METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING LIFE THREATENING COMPLICATIONS IN PATIENTS WITH MYOCARDIAL INFARCTION WITH BACKGROUND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019 |
|
RU2740896C1 |
| METHOD FOR INDIVIDUAL SELECTION OF SUPPORTING DOSE OF LEVOSIMENDAN FOR TREATING ACUTE HEART FAILURE IN ELDERLY PATIENTS IN ACUTE PHASE OF MYOCARDIAL INFARCTION | 2015 |
|
RU2601666C1 |
| METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2567827C1 |
| METHOD FOR DETERMINING DIASTOLIC DYSFUNCTION OF THE RIGHT VENTRICLE | 2018 |
|
RU2696076C1 |
| METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE WITH ISCHEMIC AND/OR POSTINFARCTION MYOCARDIAL DYSFUNCTION ACCOMPANYING CHRONIC CARDIAL INSUFFICIENCY | 2014 |
|
RU2568577C1 |
| METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
| METHOD OF REHABILITATION OF CHILDREN IN THE LONG PERIOD AFTER SURGICAL TREATMENT OF ABNORMAL DISCHARGE OF THE LEFT CORONARY ARTERY FROM THE PULMONARY ARTERY | 2022 |
|
RU2801967C1 |
| METHOD OF TREATING CARDIOVASCULAR PATIENTS AFTER SUFFERING ACUTE CORONARY SYNDROME AND CARDIOSURGICAL INTERVENTIONS | 2019 |
|
RU2715209C1 |
